• 1. A highly efficient way to capture CX2 (O, S) mildly in reusable ReILs at atmospheric pressure
  Hui Zheng,Xianting Cao,Kui Du,Jun Xu,Pengfei Zhang Green Chem. 2014 16 3142
• 2. Efficient synthesis of quinazoline-2,4(1H,3H)-diones from CO2 using ionic liquids as a dual solvent–catalyst at atmospheric pressure
  Wenjing Lu,Jun Ma,Jiayin Hu,Jinliang Song,Zhaofu Zhang,Guanying Yang,Buxing Han Green Chem. 2014 16 221
• 3. Choline hydroxide promoted chemical fixation of CO2 to quinazoline-2,4(1H,3H)-diones in water
  Wenjing Lu,Jun Ma,Jiayin Hu,Zhaofu Zhang,Congyi Wu,Buxing Han RSC Adv. 2014 4 50993
• 4. Efficient synthesis of quinazoline-2,4(1H,3H)-diones from CO2 catalyzed by N-heterocyclic carbene at atmospheric pressure
  Yunqing Xiao,Xianqiang Kong,Zhicheng Xu,Changsheng Cao,Guangsheng Pang,Yanhui Shi RSC Adv. 2015 5 5032
• 5. La–Mg mixed oxide as a highly basic water resistant catalyst for utilization of CO2 in the synthesis of quinazoline-2,4(1H,3H)-dione
  Kalidas B. Rasal,Ganapati D. Yadav RSC Adv. 2016 6 111079

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Quinazolines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Benzodiazines Quinazolines

Recent Advances in the Study of 6-Chloroquinazoline (CAS: 700-78-7) and Its Applications in Chemical Biology and Medicine

6-Chloroquinazoline (CAS: 700-78-7) is a heterocyclic compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its versatile pharmacological properties. Recent studies have highlighted its potential as a key scaffold in the development of novel therapeutic agents, particularly in oncology and infectious diseases. This research brief aims to summarize the latest findings related to 6-Chloroquinazoline, focusing on its synthesis, biological activities, and applications in drug discovery.

One of the most notable advancements in the study of 6-Chloroquinazoline is its role as a precursor in the synthesis of kinase inhibitors. Kinases are critical targets in cancer therapy, and recent research has demonstrated that 6-Chloroquinazoline derivatives exhibit potent inhibitory effects against epidermal growth factor receptor (EGFR) and other tyrosine kinases. A 2023 study published in the Journal of Medicinal Chemistry reported the development of a series of 6-Chloroquinazoline-based compounds with nanomolar affinity for EGFR mutants, showcasing their potential as next-generation anticancer agents.

In addition to its applications in oncology, 6-Chloroquinazoline has also been investigated for its antimicrobial properties. A recent study in Bioorganic & Medicinal Chemistry Letters identified several 6-Chloroquinazoline derivatives with broad-spectrum activity against drug-resistant bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA). These findings suggest that 6-Chloroquinazoline could serve as a promising scaffold for the development of new antibiotics to address the growing threat of antimicrobial resistance.

Another area of interest is the use of 6-Chloroquinazoline in the design of fluorescent probes for biological imaging. Researchers have exploited the compound's unique photophysical properties to develop probes for detecting reactive oxygen species (ROS) in cellular environments. A 2022 study in Chemical Communications detailed the synthesis of a 6-Chloroquinazoline-based probe capable of selectively imaging ROS in live cells, offering new tools for studying oxidative stress-related diseases.

Despite these promising developments, challenges remain in the optimization of 6-Chloroquinazoline derivatives for clinical use. Issues such as bioavailability, metabolic stability, and off-target effects need to be addressed through further structure-activity relationship (SAR) studies. Recent efforts have focused on modifying the core scaffold to improve pharmacokinetic properties, as evidenced by a 2023 patent application describing novel 6-Chloroquinazoline prodrugs with enhanced solubility and tissue penetration.

In conclusion, 6-Chloroquinazoline (CAS: 700-78-7) continues to be a valuable compound in chemical biology and medicinal research. Its diverse applications, from kinase inhibition to antimicrobial activity and molecular imaging, underscore its potential as a multifunctional scaffold. Future research should prioritize the translation of these findings into clinically viable therapeutics, leveraging advances in synthetic chemistry and drug delivery technologies to overcome current limitations.

• 20028-71-1(6-Chloroquinazolin-2-amine)
• 88368-34-7(7H-Pyrimido[5,4-c]carbazole, 9-chloro-)
• 88368-35-8(7H-Pyrimido[5,4-c]carbazole, 8,10-dichloro-)
• 190273-70-2(2-Amino-5-chloroquinazoline)
• 190274-08-9(2-Amino-7-chloroquinazoline)
• 218-20-2(Naphtho[1,2-h]quinazoline(8CI,9CI))
• 253-82-7(Quinazoline)
• 257-82-9(Naphtho[2,3-g]quinazoline(8CI,9CI))
• 229-75-4(Benzo[f]quinazoline)
• 61959-57-7(Benzo[f]pyrimido[4,5-h]quinazoline)